Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores.

Broekman KE, Jalving M, van Tinteren H, Sessa C, Reyners AKL.

Cancer Treat Rev. 2018 Sep;69:233-242. doi: 10.1016/j.ctrv.2018.06.008. Epub 2018 Jun 18. Review.

2.

Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands.

van Broekhoven DLM, Verschoor AJ, van Dalen T, Grünhagen DJ, den Bakker MA, Gelderblom H, Bovee JVMG, Haas RLM, Bonenkamp HJ, van Coevorden F, Ten Oever D, van der Graaf WTA, Flucke UE, Pras E, Reyners AKL, Westermann AM, Oldenburger F, Verhoef C, Steeghs N.

Sarcoma. 2018 Jun 21;2018:5982575. doi: 10.1155/2018/5982575. eCollection 2018.

3.

Outcome in patients perceived as receiving excessive care across different ethical climates: a prospective study in 68 intensive care units in Europe and the USA.

Benoit DD, Jensen HI, Malmgren J, Metaxa V, Reyners AK, Darmon M, Rusinova K, Talmor D, Meert AP, Cancelliere L, Zubek L, Maia P, Michalsen A, Vanheule S, Kompanje EJO, Decruyenaere J, Vandenberghe S, Vansteelandt S, Gadeyne B, Van den Bulcke B, Azoulay E, Piers RD; DISPROPRICUS study group of the Ethics Section of the European Society of Intensive Care Medicine.

Intensive Care Med. 2018 Jul;44(7):1039-1049. doi: 10.1007/s00134-018-5231-8. Epub 2018 May 28.

4.

Feasibility of hospital-initiated non-facilitator assisted advance care planning documentation for patients with palliative care needs.

Kok M, van der Werff GFM, Geerling JI, Ruivenkamp J, Groothoff W, van der Velden AWG, Thoma M, Talsma J, Costongs LGP, Gans ROB, de Graeff P, Reyners AKL.

BMC Palliat Care. 2018 May 24;17(1):79. doi: 10.1186/s12904-018-0331-3.

5.

Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.

Caumanns JJ, Berns K, Wisman GBA, Fehrmann RSN, Tomar T, Klip H, Meersma GJ, Hijmans EM, Gennissen AMC, Duiker EW, Weening D, Itamochi H, Kluin RJC, Reyners AKL, Birrer MJ, Salvesen HB, Vergote I, van Nieuwenhuysen E, Brenton J, Braicu EI, Kupryjanczyk J, Spiewankiewicz B, Mittempergher L, Bernards R, van der Zee AGJ, de Jong S.

Clin Cancer Res. 2018 Aug 15;24(16):3928-3940. doi: 10.1158/1078-0432.CCR-17-3060. Epub 2018 Apr 23.

PMID:
29685880
6.

A single digital droplet PCR assay to detect multiple KIT exon 11 mutations in tumor and plasma from patients with gastrointestinal stromal tumors.

Boonstra PA, Ter Elst A, Tibbesma M, Bosman LJ, Mathijssen R, Atrafi F, van Coevorden F, Steeghs N, Farag S, Gelderblom H, van der Graaf WTA, Desar IME, Maier J, Overbosch J, Suurmeijer AJH, Gietema J, Schuuring E, Reyners AKL.

Oncotarget. 2018 Feb 14;9(17):13870-13883. doi: 10.18632/oncotarget.24493. eCollection 2018 Mar 2.

7.

Ethical decision-making climate in the ICU: theoretical framework and validation of a self-assessment tool.

Van den Bulcke B, Piers R, Jensen HI, Malmgren J, Metaxa V, Reyners AK, Darmon M, Rusinova K, Talmor D, Meert AP, Cancelliere L, Zubek L, Maia P, Michalsen A, Decruyenaere J, Kompanje EJO, Azoulay E, Meganck R, Van de Sompel A, Vansteelandt S, Vlerick P, Vanheule S, Benoit DD.

BMJ Qual Saf. 2018 Feb 23. pii: bmjqs-2017-007390. doi: 10.1136/bmjqs-2017-007390. [Epub ahead of print]

PMID:
29475979
8.

Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature.

Boonstra PA, Gietema JA, Suurmeijer AJH, Groves MR, de Assis Batista F, Schuuring E, Reyners AKL.

Oncotarget. 2017 Nov 26;8(65):109836-109847. doi: 10.18632/oncotarget.22663. eCollection 2017 Dec 12.

9.

A systematic review of the effectiveness of patient-based educational interventions to improve cancer-related pain.

Oldenmenger WH, Geerling JI, Mostovaya I, Vissers KCP, de Graeff A, Reyners AKL, van der Linden YM.

Cancer Treat Rev. 2018 Feb;63:96-103. doi: 10.1016/j.ctrv.2017.12.005. Epub 2017 Dec 13. Review.

10.

Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients.

Farag S, van Coevorden F, Sneekes E, Grunhagen DJ, Reyners AKL, Boonstra PA, van der Graaf WT, Gelderblom HJ, Steeghs N.

Eur J Cancer. 2017 Nov;86:318-325. doi: 10.1016/j.ejca.2017.09.017. Epub 2017 Oct 23.

PMID:
29073582
11.

Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib.

Verboom MC, Kloth JSL, Swen JJ, van der Straaten T, Bovée JVMG, Sleijfer S, Reyners AKL, Mathijssen RHJ, Guchelaar HJ, Steeghs N, Gelderblom H.

Eur J Cancer. 2017 Nov;86:226-232. doi: 10.1016/j.ejca.2017.09.025. Epub 2017 Oct 18.

PMID:
29054076
12.

Early Evaluation of Response Using 18F-FDG PET Influences Management in Gastrointestinal Stromal Tumor Patients Treated with Neoadjuvant Imatinib.

Farag S, Geus-Oei LF, van der Graaf WT, van Coevorden F, Grunhagen D, Reyners AKL, Boonstra PA, Desar I, Gelderblom H, Steeghs N.

J Nucl Med. 2018 Feb;59(2):194-196. doi: 10.2967/jnumed.117.196642. Epub 2017 Sep 28.

PMID:
28970330
13.

IGF system targeted therapy: Therapeutic opportunities for ovarian cancer.

Liefers-Visser JAL, Meijering RAM, Reyners AKL, van der Zee AGJ, de Jong S.

Cancer Treat Rev. 2017 Nov;60:90-99. doi: 10.1016/j.ctrv.2017.08.012. Epub 2017 Sep 8. Review.

14.

Screening for psychological distress before radiotherapy for painful bone metastases may be useful to identify patients with high levels of distress.

Westhoff PG, de Graeff A, Monninkhof EM, Berveling MJ, van Vulpen M, Leer JWH, Marijnen CAM, Reyners AKL, van der Linden YM; Dutch Bone Metastasis Study Group.

Acta Oncol. 2017 Dec;56(12):1720-1727. doi: 10.1080/0284186X.2017.1374557. Epub 2017 Sep 12.

PMID:
28893119
15.

Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82-90].

Eggink FA, Mom CH, Bouwman K, Boll D, Becker JH, Creutzberg CL, Niemeijer GC, van Driel WJ, Reyners AK, van der Zee AG, Bremer GL, Ezendam NP, Kruitwagen RF, Pijnenborg JM, Hollema H, Nijman HW, van der Aa MA.

Eur J Cancer. 2017 Oct;84:370. doi: 10.1016/j.ejca.2017.08.003. Epub 2017 Aug 23. No abstract available.

PMID:
28844347
16.

Web-Based Tailored Psychoeducation for Breast Cancer Patients at the Onset of the Survivorship Phase: A Multicenter Randomized Controlled Trial.

Admiraal JM, van der Velden AWG, Geerling JI, Burgerhof JGM, Bouma G, Walenkamp AME, de Vries EGE, Schröder CP, Reyners AKL.

J Pain Symptom Manage. 2017 Oct;54(4):466-475. doi: 10.1016/j.jpainsymman.2017.07.009. Epub 2017 Jul 13.

PMID:
28711750
17.

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.

Eggink FA, Mom CH, Bouwman K, Boll D, Becker JH, Creutzberg CL, Niemeijer GC, van Driel WJ, Reyners AK, van der Zee AG, Bremer GL, Ezendam NP, Kruitwagen RF, Pijnenborg JM, Hollema H, Nijman HW, van der Aa MA.

Eur J Cancer. 2017 Jun;78:82-90. doi: 10.1016/j.ejca.2017.03.010. Epub 2017 Apr 14. Erratum in: Eur J Cancer. 2017 Oct;84:370.

PMID:
28415003
18.

Increased life expectancy as a result of non-hormonal targeted therapies for HER2 or hormone receptor positive metastatic breast cancer: A systematic review and meta-analysis.

Koleva-Kolarova RG, Oktora MP, Robijn AL, Greuter MJW, Reyners AKL, Buskens E, de Bock GH.

Cancer Treat Rev. 2017 Apr;55:16-25. doi: 10.1016/j.ctrv.2017.01.001. Epub 2017 Feb 20. Review.

PMID:
28288388
19.

Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients.

Farag S, Somaiah N, Choi H, Heeres B, Wang WL, van Boven H, Nederlof P, Benjamin R, van der Graaf W, Grunhagen D, Boonstra PA, Reyners AK, Gelderblom H, Steeghs N.

Eur J Cancer. 2017 May;76:76-83. doi: 10.1016/j.ejca.2017.02.007. Epub 2017 Mar 8.

PMID:
28284172
20.

Web-based information and support for patients with a newly diagnosed neuroendocrine tumor: a feasibility study.

Bouma G, de Hosson LD, van Woerkom CE, van Essen H, de Bock GH, Admiraal JM, Reyners AKL, Walenkamp AME.

Support Care Cancer. 2017 Jul;25(7):2075-2083. doi: 10.1007/s00520-017-3598-7. Epub 2017 Feb 9.

21.

Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study.

Verboom MC, Ouwerkerk J, Steeghs N, Lutjeboer J, Martijn Kerst J, van der Graaf WTA, Reyners AKL, Sleijfer S, Gelderblom H.

Clin Sarcoma Res. 2017 Jan 31;7:2. doi: 10.1186/s13569-017-0066-6. eCollection 2017.

22.

Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinib.

Kloth JSL, Verboom MC, Swen JJ, van der Straaten T, Sleijfer S, Reyners AKL, Steeghs N, Gelderblom H, Guchelaar HJ, Mathijssen RHJ.

Pharmacogenomics J. 2018 Jan;18(1):49-55. doi: 10.1038/tpj.2016.83. Epub 2017 Jan 24.

PMID:
28117434
23.

Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options.

van Leeuwen RWF, Jansman FGA, Hunfeld NG, Peric R, Reyners AKL, Imholz ALT, Brouwers JRBJ, Aerts JG, van Gelder T, Mathijssen RHJ.

Clin Pharmacokinet. 2017 Jul;56(7):683-688. doi: 10.1007/s40262-016-0503-3.

24.

Study protocol for the OPTion randomised controlled trial on the effect of prioritising treatment goals among older patients with cancer in a palliative setting.

Stegmann ME, Schuling J, Hiltermann TJ, Reyners AK, Burger H, Berger MY, Berendsen AJ.

Maturitas. 2017 Feb;96:84-88. doi: 10.1016/j.maturitas.2016.11.014. Epub 2016 Nov 27.

PMID:
28041600
25.

[Vismodegib for basal cell carcinoma: targeted therapy in case of locally advanced or metastasised disease].

Reinders MG, Terra JB, Reyners AK, Aarts MJ, de Haas ER, Mosterd K.

Ned Tijdschr Geneeskd. 2016;160:D187. Dutch.

PMID:
28000572
26.

Metallic Taste in Cancer Patients Treated with Systemic Therapy: A Questionnaire-based Study.

IJpma I, Timmermans ER, Renken RJ, Ter Horst GJ, Reyners AK.

Nutr Cancer. 2017 Jan;69(1):140-145. doi: 10.1080/01635581.2017.1250922. Epub 2016 Dec 7.

PMID:
27925850
27.

Changes in taste and smell function, dietary intake, food preference, and body composition in testicular cancer patients treated with cisplatin-based chemotherapy.

IJpma I, Renken RJ, Gietema JA, Slart RHJA, Mensink MGJ, Lefrandt JD, Ter Horst GJ, Reyners AKL.

Clin Nutr. 2017 Dec;36(6):1642-1648. doi: 10.1016/j.clnu.2016.10.013. Epub 2016 Oct 27.

PMID:
27836309
28.

Cancer patients' referral wish: effects of distress, problems, socio-demographic and illness-related variables and social support sufficiency.

Admiraal JM, van Nuenen FM, Burgerhof JG, Reyners AK, Hoekstra-Weebers JE.

Psychooncology. 2016 Nov;25(11):1363-1370. doi: 10.1002/pon.4067. Epub 2016 Jan 25.

PMID:
26804486
29.

Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer.

Fedoseienko A, Wieringa HW, Wisman GB, Duiker E, Reyners AK, Hofker MH, van der Zee AG, van de Sluis B, van Vugt MA.

PLoS One. 2016 Oct 27;11(10):e0165385. doi: 10.1371/journal.pone.0165385. eCollection 2016.

30.

Predictors of enduring clinical distress in women with breast cancer.

Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MB, Reyners AK, Russell NS, Schriek M, Sijtsema S, van Tienhoven G, Sprangers MA.

Breast Cancer Res Treat. 2016 Aug;158(3):563-72. doi: 10.1007/s10549-016-3896-7. Epub 2016 Jul 14.

31.

Don't forget the dentist: Dental care use and needs of women with breast cancer.

Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MB, Reyners AK, Russell NS, Schriek M, Sijtsema S, van Tienhoven G, Sprangers MA.

Breast. 2016 Oct;29:1-7. doi: 10.1016/j.breast.2016.06.012. Epub 2016 Jul 1.

PMID:
27376886
32.

Taste and smell function in testicular cancer survivors treated with cisplatin-based chemotherapy in relation to dietary intake, food preference, and body composition.

IJpma I, Renken RJ, Gietema JA, Slart RH, Mensink MG, Lefrandt JD, Ter Horst GJ, Reyners AK.

Appetite. 2016 Oct 1;105:392-9. doi: 10.1016/j.appet.2016.06.010. Epub 2016 Jun 10.

PMID:
27298084
33.

The palatability of oral nutritional supplements: before, during, and after chemotherapy.

IJpma I, Renken RJ, Ter Horst GJ, Reyners AK.

Support Care Cancer. 2016 Oct;24(10):4301-8. doi: 10.1007/s00520-016-3263-6. Epub 2016 May 24.

34.

Molecular imaging in ovarian cancer.

Reyners AK, Broekman KE, Glaudemans AW, Brouwers AH, Arts HJ, van der Zee AG, de Vries EG, Jalving M.

Ann Oncol. 2016 Apr;27 Suppl 1:i23-i29. doi: 10.1093/annonc/mdw091. Review.

PMID:
27141066
35.

Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands.

Eggink FA, Mom CH, Kruitwagen RF, Reyners AK, Van Driel WJ, Massuger LF, Niemeijer GC, Van der Zee AG, Van der Aa MA, Nijman HW.

Gynecol Oncol. 2016 Jun;141(3):524-530. doi: 10.1016/j.ygyno.2016.04.012. Epub 2016 Apr 23.

PMID:
27090157
36.

A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer.

Dijkgraaf EM, Santegoets SJ, Reyners AK, Goedemans R, Nijman HW, van Poelgeest MI, van Erkel AR, Smit VT, Daemen TA, van der Hoeven JJ, Melief CJ, Welters MJ, Kroep JR, van der Burg SH.

Oncotarget. 2015 Oct 13;6(31):32228-43. doi: 10.18632/oncotarget.4772.

37.

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.

Dijkgraaf EM, Santegoets SJ, Reyners AK, Goedemans R, Wouters MC, Kenter GG, van Erkel AR, van Poelgeest MI, Nijman HW, van der Hoeven JJ, Welters MJ, van der Burg SH, Kroep JR.

Ann Oncol. 2015 Oct;26(10):2141-9. doi: 10.1093/annonc/mdv309. Epub 2015 Jul 27.

PMID:
26216383
38.

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.

Bui-Nguyen B, Butrynski JE, Penel N, Blay JY, Isambert N, Milhem M, Kerst JM, Reyners AK, Litière S, Marréaud S, Collin F, van der Graaf WT; European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC/STBSG) and the Sarcoma Alliance for Research through Collaboration (SARC).

Eur J Cancer. 2015 Jul;51(10):1312-20. doi: 10.1016/j.ejca.2015.03.023. Epub 2015 Apr 23.

PMID:
25912752
39.

Internet-based support programs to alleviate psychosocial and physical symptoms in cancer patients: a literature analysis.

Bouma G, Admiraal JM, de Vries EG, Schröder CP, Walenkamp AM, Reyners AK.

Crit Rev Oncol Hematol. 2015 Jul;95(1):26-37. doi: 10.1016/j.critrevonc.2015.01.011. Epub 2015 Jan 31. Review.

PMID:
25701515
40.

Metallic taste in cancer patients treated with chemotherapy.

IJpma I, Renken RJ, Ter Horst GJ, Reyners AK.

Cancer Treat Rev. 2015 Feb;41(2):179-86. doi: 10.1016/j.ctrv.2014.11.006. Epub 2014 Dec 5. Review.

PMID:
25499998
41.

Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16α-18F-fluoro-17β-estradiol PET/CT.

van Kruchten M, de Vries EF, Arts HJ, Jager NM, Bongaerts AH, Glaudemans AW, Hollema H, de Vries EG, Hospers GA, Reyners AK.

J Nucl Med. 2015 Jan;56(1):50-5. doi: 10.2967/jnumed.114.147579. Epub 2014 Dec 4.

42.

A 21-year-old patient with a HER2-positive colorectal cancer.

Bensch F, van Rooijen JM, Schröder CP, Reyners AK.

Gastroenterology. 2015 Jan;148(1):20-1. doi: 10.1053/j.gastro.2014.09.046. Epub 2014 Nov 5. No abstract available.

PMID:
25447849
43.

Radical surgery in patients with residual disease after (chemo)radiation for cervical cancer.

Boers A, Arts HJ, Klip H, Nijhuis ER, Pras E, Hollema H, Wisman GB, Nijman HW, Mourits MJ, Reyners AK, de Bock GH, Thomas G, van der Zee AG.

Int J Gynecol Cancer. 2014 Sep;24(7):1276-85. doi: 10.1097/IGC.0000000000000171.

PMID:
24987914
44.

Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial.

Westhoff PG, de Graeff A, Geerling JI, Reyners AK, van der Linden YM.

BMC Cancer. 2014 May 20;14:347. doi: 10.1186/1471-2407-14-347.

45.

Inappropriate care in European ICUs: confronting views from nurses and junior and senior physicians.

Piers RD, Azoulay E, Ricou B, DeKeyser Ganz F, Max A, Michalsen A, Azevedo Maia P, Owczuk R, Rubulotta F, Meert AP, Reyners AK, Decruyenaere J, Benoit DD; Appropricus Study Group of the Ethics Section of the European Society of Intensive Care Medicine.

Chest. 2014 Aug;146(2):267-275. doi: 10.1378/chest.14-0256.

PMID:
24832567
46.

Effect of age on response to palliative radiotherapy and quality of life in patients with painful bone metastases.

Westhoff PG, de Graeff A, Reyners AK, Monninkhof EM, Rodenhuis CC, van Vulpen M, Leer JW, Marijnen CA, van der Linden YM; Dutch Bone Metastasis Study Group.

Radiother Oncol. 2014 May;111(2):264-9. doi: 10.1016/j.radonc.2014.03.017. Epub 2014 Apr 17.

PMID:
24746581
47.

Positron emission tomography imaging of oestrogen receptor-expression in endometrial stromal sarcoma supports oestrogen receptor-targeted therapy: case report and review of the literature.

van Kruchten M, Hospers GA, Glaudemans AW, Hollema H, Arts HJ, Reyners AK.

Eur J Cancer. 2013 Dec;49(18):3850-5. doi: 10.1016/j.ejca.2013.08.005. Epub 2013 Sep 2. Review.

PMID:
24007820
48.

Heart rate variability parameters do not correlate with pain intensity in healthy volunteers.

Meeuse JJ, Löwik MS, Löwik SA, Aarden E, van Roon AM, Gans RO, van Wijhe M, Lefrandt JD, Reyners AK.

Pain Med. 2013 Aug;14(8):1192-201. doi: 10.1111/pme.12133. Epub 2013 May 9.

PMID:
23659489
49.

Do cancer and treatment type affect distress?

Admiraal JM, Reyners AK, Hoekstra-Weebers JE.

Psychooncology. 2013 Aug;22(8):1766-73. doi: 10.1002/pon.3211. Epub 2012 Oct 29.

PMID:
23109282
50.

Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.

Lybol C, Thomas CM, Blanken EA, Sweep FC, Verheijen RH, Westermann AM, Boere IA, Reyners AK, Massuger LF, van Hoesel RQ, Ottevanger PB.

Eur J Cancer. 2013 Mar;49(4):860-7. doi: 10.1016/j.ejca.2012.09.015. Epub 2012 Oct 23.

Supplemental Content

Loading ...
Support Center